Raman mapping for kinetic analysis of crystallization of amorphous drug based on distributional images

International Journal of Pharmaceutics

Volumn 462, Issue 1-2, 2014, Pages 115-122

  Ueda, Hiroshi ^a,b   Ida, Yasuo ^a   Kadota, Kazunori ^b   Tozuka, Yuichi ^b  

^a SHIONOGI AND CO LTD   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Amorphous drug; Crystallization mechanism; Kinetic analysis; Raman mapping

Indexed keywords

INDOMETACIN;

ARTICLE; CRYSTALLIZATION; HUMAN; KINETICS; PARTICLE SIZE; PREDICTION; PRIORITY JOURNAL; RAMAN MAPPING; RAMAN SPECTROMETRY; SPECTRUM; STORAGE; X RAY POWDER DIFFRACTION;

AMORPHOUS DRUG; CRYSTALLIZATION MECHANISM; KINETIC ANALYSIS; RAMAN MAPPING;

CALORIMETRY, DIFFERENTIAL SCANNING; CRYSTALLIZATION; FEASIBILITY STUDIES; INDOMETHACIN; KINETICS; PARTICLE SIZE; SPECTRUM ANALYSIS, RAMAN; X-RAY DIFFRACTION;

EID: 84892618704     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.12.025     Document Type: Article

References (22)

1. V. Andronis, M. Yoshioka, and G. Zografi Effects of sorbed water on the crystallization of indomethacin from the amorphous state J. Pharm. Sci. 86 1997 346 351
2. G. Buckton, A. Ambarkhane, and K. Pincott The use of inverse phase gas chromatography to study the glass transition temperature of a powder surface Pharm. Res. 21 2004 1554 1557
3. K.J. Crowley, and G. Zografi Cryogenic grinding of indomethacin polymorphs and solvates: assessment of amorphous phase formation and amorphous phase physical stability J. Pharm. Sci. 91 2002 492 507
4. K.J. Crowley, and G. Zografi The effect of low concentrations of molecularly dispersed poly(vinylpyrrolidone) on indomethacin crystallization from the amorphous state Pharm. Res. 20 2003 1417 1422
5. N. Furuyama, S. Hasegawa, T. Hamaura, S. Yada, H. Nakagami, E. Yonemochi, and K. Terada Evaluation of solid dispersions on a molecular level by the Raman mapping technique Int. J. Pharm. 361 2008 12 18
6. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, 2005. ICH harmonised tripartite guideline validation of analytical procedures: text and methodology Q2(R1).
7. N. Kaneniwa, M. Otsuka, and T. Hayashi Physicochemical characterization of indomethacin polymorphs and the transformation kinetics in ethanol Chem. Pharm. Bull. 33 1985 3447 3455
8. X. Li, and S.L. Nail Kinetics of glycine crystallization during freezing of sucrose/glycine excipient systems J. Pharm. Sci. 94 2005 625 631
9. T. Matsumoto, and G. Zografi Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization Pharm. Res. 16 1999 1722 1728
10. L.H. Nielsen, S.S. Keller, K.C. Gordon, A. Boisen, T. Rades, and A. Müllertz Spatial confinement can lead to increased stability of amorphous indomethacin Eur. J. Pharm. Biopharm. 81 2012 418 425
11. T. Okumura, and M. Otsuka Evaluation of the microcrystallinity of a drug substance, indomethacin, in a pharmaceutical model tablet by chemometric FT-Raman spectroscopy Pharm. Res. 22 2005 1350 1357
12. X. Pan, T. Julian, and L. Augsburger Quantitative measurement of indomethacin crystallinity in indomethacin-silica gel binary system using differential scanning calorimetry and X-ray powder diffractometry AAPS PharmSciTech 10 2006 E1 E7
13. F. Qian, J. Huang, Q. Zhu, R. Haddadin, J. Gawel, R. Garmise, and M. Hussain Is a distinctive single Tg a reliable indicator for the homogeneity of amorphous solid dispersion? Int. J. Pharm. 395 2010 232 235
14. L. Saerens, L. Dierickx, B. Lenain, C. Vervaet, J.P. Remon, and T. De Beer Raman spectroscopy for the in-line polymer-drug quantification and solid state characterization during a pharmaceutical hot-melt extrusion process Eur. J. Pharm. Biopharm. 77 2011 158 163
15. L.S. Taylor, and G. Zografi Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions Pharm. Res. 14 1997 1691 1698
16. L.S. Taylor, and G. Zografi The quantitative analysis of crystallinity using FT-Raman spectroscopy Pharm. Res. 15 1998 755 761
17. M. Vasanthavada, W.Q. Tong, Y. Joshi, and M.S. Kislalioglu Phase behavior of amorphous molecular dispersions. II: Role of hydrogen bonding in solid solubility and phase separation kinetics Pharm. Res. 22 2005 440 448
18. T. Watanabe, N. Wakiyama, F. Usui, M. Ikeda, T. Isobe, and M. Senna Stability of amorphous indomethacin compounded with silica Int. J. Pharm. 226 2001 81 91
19. E. Widjaja, P. Kanaujia, G. Lau, W.K. Ng, M. Garland, C. Saal, A. Hanefeld, M. Fischbach, M. Maio, and R.B. Tan Detection of trace crystallinity in an amorphous system using Raman microscopy and chemometric analysis Eur. J. Pharm. Sci. 42 2011 45 54
20. M. Yoshioka, B.C. Hancock, and G. Zografi Crystallization of indomethacin from the amorphous state below and above its glass transition temperature J. Pharm. Sci. 83 1994 1700 1705
21. L. Zhu, J. Jona, K. Nagapudi, and T. Wu Fast surface crystallization of amorphous griseofulvin below Tg Pharm. Res. 27 2010 1558 1567
22. A.S. Zidan, Z. Rahman, V. Sayeed, A. Raw, L. Yu, and M.A. Khan Crystallinity evaluation of tacrolimus solid dispersions by chemometric analysis Int. J. Pharm. 423 2012 341 350